MarketCapTrends
AGIO

Agios Pharmaceuticals Inc. (AGIO)

NASDAQ · Healthcare

Agios Pharmaceuticals Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Agios Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 104.1M, a 14.83% decrease year-over-year.
  • Agios Pharmaceuticals Inc. total liabilities for 2025 were 104.1M, a 14.83% decrease from 2024.
  • Agios Pharmaceuticals Inc. total liabilities for 2024 were 122.2M, a 3.06% decrease from 2023.
  • Agios Pharmaceuticals Inc. total liabilities for 2023 were 126.1M, a 8.56% decrease from 2022.
  • Agios Pharmaceuticals Inc. total liabilities for 2022 were 137.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Agios Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $)
2025$104
2024$122
2023$126
2022$138
2021$146
2020$453
2019$250
2018$171
2017$239
2016$261
Agios Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$104
2024-12-31$122
2023-12-31$126
2022-12-31$138
2021-12-31$146
2020-12-31$453
2019-12-31$250
2018-12-31$171
2017-12-31$239
2016-12-31$261

Agios Pharmaceuticals Inc. Total Liabilities — FAQ

Agios Pharmaceuticals Inc. (AGIO) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AGIO's total liabilities history?

The chart and table above show Agios Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.